| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Anavex Life Sciences Corp. (LSE: 0HFR)
0HFR Technical Analysis
5
| As on 14th Nov 2025 0HFR STOCK Price closed @ 3.99 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.37 & Strong Sell for SHORT-TERM with Stoploss of 5.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0HFRSTOCK Price
| Open | 5.24 | Change | Price | % |
| High | 6.00 | 1 Day | -2.05 | -33.94 |
| Low | 2.73 | 1 Week | -3.29 | -45.19 |
| Close | 3.99 | 1 Month | -5.64 | -58.57 |
| Volume | 133467 | 1 Year | -0.09 | -2.21 |
| 52 Week High 14.00 | 52 Week Low 3.67 | ||||
LSE UK Most Active Stocks
| ALBA | 0.02 | 0.00% |
| UKOG | 0.01 | 0.00% |
| EME | 0.14 | 0.00% |
| TRP | 0.03 | 0.00% |
| MSMN | 0.02 | 0.00% |
| DEMG | 0.02 | -50.00% |
| SMDS | 582.50 | 0.00% |
| HE1 | 0.38 | -5.00% |
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| 0HFR Daily Charts |
0HFR Intraday Charts |
Whats New @ Bazaartrend |
0HFR Free Analysis |
|
|
0HFR Important Levels Intraday
| RESISTANCE | 10.29 |
| RESISTANCE | 8.27 |
| RESISTANCE | 7.02 |
| RESISTANCE | 5.77 |
| SUPPORT | 2.21 |
| SUPPORT | 0.96 |
| SUPPORT | -0.29 |
| SUPPORT | -2.31 |
0HFR Forecast November 2025
| 4th UP Forecast | 11.35 |
| 3rd UP Forecast | 8.99 |
| 2nd UP Forecast | 7.53 |
| 1st UP Forecast | 6.07 |
| 1st DOWN Forecast | 1.91 |
| 2nd DOWN Forecast | 0.45 |
| 3rd DOWN Forecast | -1.01 |
| 4th DOWN Forecast | -3.37 |
0HFR Weekly Forecast
| 4th UP Forecast | 5.05 |
| 3rd UP Forecast | 4.71 |
| 2nd UP Forecast | 4.50 |
| 1st UP Forecast | 4.29 |
| 1st DOWN Forecast | 3.69 |
| 2nd DOWN Forecast | 3.48 |
| 3rd DOWN Forecast | 3.27 |
| 4th DOWN Forecast | 2.93 |
0HFR Forecast2025
| 4th UP Forecast | 26.57 |
| 3rd UP Forecast | 19.33 |
| 2nd UP Forecast | 14.85 |
| 1st UP Forecast | 10.38 |
| 1st DOWN Forecast | -2.4 |
| 2nd DOWN Forecast | -6.87 |
| 3rd DOWN Forecast | -11.35 |
| 4th DOWN Forecast | -18.59 |
Anavex Life Sciences Corp. ( LSE UK Symbol : 0HFR )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0HFR Business Profile
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials to treat Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company is based in New York, New York. Address: 51 West 52nd Street, New York, NY, United States, 10019
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service